David Goodlett

David Goodlett is a Professor and Director of the UVIC Genome BC Proteomics Centre in the Department of Biochemistry and Microbiology at the University of Victoria. He holds a BSc and PhD from North Carolina State University (NCSU). His research focuses on host-pathogen interactions, lipid A structure-activity relationships, microbial diagnostics, and proteomics-driven systems biology. Dr. Goodlett leads a lab developing mass spectrometry-based technologies, including lipidomics and MALDI-TOF MS for rapid bacterial identification.

Education:

• BSc, North Carolina State University
• PhD, North Carolina State University

Research Interests:

• Structural elucidation of lipid A in Gram-negative bacteria for vaccine development
• Development of mass spectrometry tools (e.g., SAWN, MALDI-TOF) for clinical diagnostics
• Proteomic profiling of cancer biomarkers and immune response mechanisms
• Bioinformatics pipelines for cross-linking mass spectrometry (CLMS)

Awards & Grants:

• NIH R01 Grant GM111066-01 (2015) for MS-based bacterial identification
• Ardgour Symposium Ethos Award (2011) for collaborative research excellence

Lab & Collaborations:

• Led development of the xComb software for cross-linked peptide analysis
• Partnerships with Deurion for commercializing SAWN technology
• FiDiPro Finland Distinguished Professorship (2014-2016) for diabetes and ovarian cancer biomarker research

Students & Trainees:

• Current students: Madison Shiyuk, Bo Ren, Linda Nartey, Sophie Culos, Kate McMurray
• Prior postdocs include Pragya Singh (PhD 2011), Sunhee Jung (PhD 2011), and Scott Heron